Concord Biotech Stock Lists At 21% Premium Over IPO Price; Should You Buy, Sell Or Hold? – Top Speed News
Last Updated: August 18, 2023, 10:44 IST Concord Biotech Listing BSE, NSE: Shares of Concord Biotech listed at a premium of 21 per cent over the IPO price of Rs 741 on the exchanges in Friday’s trade. On both NSE and BSE, the share debuted at Rs 900 apiece, a premium of Rs 159 as…